Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
about
The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.Evaluating the current state of Mendelian randomization studies: a protocol for a systematic review on methodological and clinical aspects using neurodegenerative disorders as outcomeThe Role of Lifestyle Factors and Sleep Duration for Late-Onset Dementia: A Cohort StudySerum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer's Disease: A Mendelian Randomization StudyMendelian Randomization Studies of Coffee and Caffeine Consumption
P2860
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@en
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@nl
type
label
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@en
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@nl
prefLabel
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@en
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
@en
P2093
CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project
Hugh S Markus
Matthew Traylor
Stephen Burgess
P2860
P356
10.1136/BMJ.J5375
P407
P577
2017-12-06T00:00:00Z